Onderneming American BriVision (Holding) Corporation OTC Markets
Aandelen
ABVC
US0247332069
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 23-06-23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01-03-21 |
Eugene Jiang
CHM | Chairman | 38 | 01-07-15 |
Chief Tech/Sci/R&D Officer | 70 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10-07-22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01-07-15 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23-11-17 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23-11-17 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23-11-17 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Che-Wei Hsu
BRD | Director/Board Member | 43 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 878 376 | 8 003 326 ( 73,57 %) | 26 553 ( 0,2441 %) | 73,57 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |